Support Line: 01865 410 210

Support Line:
01865 410 210

Home > News 

Alzheimer’s Drug Breakthrough Shows Importance of Continued Research

Alzheimer’s Drug Breakthrough Shows Importance of Continued Research

This morning, BBC News reported on a new Alzheimer’s drug, lecanemab, that has been found in trials to slow destruction of the brain, ending years of a “100% failure rate” with Alzheimer’s therapies.

The large-scale trial of the drug involved 1,795 volunteers with early-stage Alzheimer’s who were given infusions of lecanemab every fortnight.

Not only is this a great success for the development of new Alzheimer’s therapies but shows the importance of continued research and having willing research volunteers.

There are many opportunities available across the country and in Oxfordshire to support ongoing research. You can find out more about available research opportunities and what it’s like to take part, here.

Upcoming events

Leave a comment

More news

Our Dementia Adviser, Sophie, took to the skies in aid of the service!

One of our fantastic Dementia Advisers Sophie Took completed a skydive to raise funds for Dementia Oxfordshire last Saturday. Although the morning involved a great...

Oxfordshire based Mumby’s Live-In Care has become the second sponsor for this year’s summer fete. Their generosity means that even more of the funds we...

Bike and Banter As part of Dementia Action Week, Dementia Oxfordshire’s Young Onset Dementia Team welcomed 20 people from across the county to take part...

Skip to content